Skip to Content

SARS-CoV-2 Infection Rate Low in Patients Receiving Antitumor Therapy

MONDAY, Dec. 28, 2020 -- The rate of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is 0.68 percent among patients receiving antitumor treatment, according to a research letter published online Dec. 17 in JAMA Oncology.

Carlo Aschele, M.D., Ph.D., from Ospedale Sant'Andrea in La Spezia, Italy, and colleagues calculated the rate of SARS-CoV-2 infection among patients receiving antitumor treatment at 118 medical oncology units affiliated with the Collegio Italiano dei Primari Oncologi Medici Ospedalieri in Italy. Data were included for 59,989 patients receiving antitumor treatment between Jan. 15 and May 4, 2020.

The researchers found that 406 of the patients (0.68 percent) developed COVID-19 and had a positive nasopharyngeal polymerase chain reaction test result. Most infected patients (83 percent) were symptomatic and 77 percent required hospitalization. The most common tumor was lung cancer (22 percent) and the most represented antitumor treatment was chemotherapy (62 percent). Compared with the general Italian population during the same time period, the infection rate was higher and varied between different geographical areas.

"From a clinical point of view, the low probability of SARS-CoV-2 infection among these patients (<1 percent) supports the continuation of most oncologic treatments in the adjuvant and metastatic setting," the authors write. "Based on the present data, delaying active antitumor treatment to avoid SARS-CoV-2 transmission should not be routinely recommended."

One author disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text

© 2021 HealthDay. All rights reserved.

Posted: December 2020

Read this next

Tocilizumab Does Not Improve Outcomes in Severe COVID-19

THURSDAY, Jan. 21, 2021 -- Tocilizumab plus standard care is not superior to standard care alone for improving clinical outcomes among patients with severe or critical COVID-19...

Mortality Decreased for COVID-19 ICU Patients Over Time

THURSDAY, Jan. 21, 2021 -- For adults with COVID-19-related critical illness admitted to the intensive care unit (ICU), mortality has decreased over time, according to a study...

President Biden Unveils Details of National Pandemic Response Plan

THURSDAY, Jan. 21, 2021 -- A day after his inauguration, President Joe Biden plans to unveil a new, far-reaching pandemic response plan. He will also issue executive orders that...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.